Johan Feehally

Johan Feehally's AcademicInfluence.com Rankings

Johan Feehally

Philosophy

#8356

World Rank

#11715

Historical Rank

Logic

#5389

World Rank

#6783

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Johan Feehally's Degrees

Doctorate Medicine University of Leicester

Why Is Johan Feehally Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Johan Feehally's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Kidney disease: Improving global outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis (2012) (1147)
The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. (2009) (1022)
The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. (2009) (848)
International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology (2015) (717)
Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group. (2017) (609)
Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. (2011) (431)
Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens (2014) (430)
Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments (2014) (346)
Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial (2017) (317)
Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients. (2001) (299)
Galactosylation of N‐ and O‐linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy (1995) (282)
Assessment of Global Kidney Health Care Status (2017) (269)
Recognition and management of acute kidney injury in the International Society of Nephrology 0by25 Global Snapshot: a multinational cross-sectional study (2016) (253)
A comparison of the results of renal transplantation from non-heart-beating, conventional cadaveric, and living donors. (2000) (217)
HLA has strongest association with IgA nephropathy in genome-wide analysis. (2010) (216)
Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial (2017) (213)
A Multicenter Study of the Predictive Value of Crescents in IgA Nephropathy. (2017) (199)
IgA nephropathy: recent developments. (2000) (196)
Physical Exercise in Patients with Severe Kidney Disease (2010) (179)
Increased Incidence of End‐stage Renal Failure Secondary to Diabetes Mellitus in Asian Ethnic Groups in the United Kingdom (1992) (178)
Evaluating a New International Risk-Prediction Tool in IgA Nephropathy. (2019) (174)
Comprehensive Clinical Nephrology (2000) (173)
The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults. (2010) (171)
Corticosteroids in IgA Nephropathy: A Retrospective Analysis from the VALIGA Study. (2015) (170)
Abnormal IgA glycosylation in Henoch-Schönlein purpura restricted to patients with clinical nephritis. (1998) (170)
Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial (2013) (152)
Leucocyte beta 1,3 galactosyltransferase activity in IgA nephropathy. (1997) (149)
High prevalence of systemic disease and mortality in Asian subjects with systemic lupus erythematosus. (1991) (147)
An update on the pathogenesis and treatment of IgA nephropathy. (2012) (139)
Evidence for anti-inflammatory effects of exercise in CKD. (2014) (134)
Systemic Vasculitis in the 1980s—Is There an Increasing Incidence of Wegener's Graanulomatosis and Microscopic Polyarteritis? (1990) (114)
The MEST score provides earlier risk prediction in lgA nephropathy. (2016) (113)
Analysis of IgA1 O-glycans in IgA nephropathy by fluorophore-assisted carbohydrate electrophoresis. (1999) (112)
Increased dimeric IgA producing B cells in the bone marrow in IgA nephropathy determined by in situ hybridisation for J chain mRNA. (1996) (112)
O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy. (2006) (111)
Global nephrology workforce: gaps and opportunities toward a sustainable kidney care system. (2018) (110)
Status of care for end stage kidney disease in countries and regions worldwide: international cross sectional survey (2019) (109)
Pathogenesis of IgA nephropathy. (1999) (105)
The MEST score provides earlier risk prediction in IgA nephropathy. (2015) (104)
O-glycosylation of serum IgD in IgA nephropathy. (2006) (103)
The mucosa–kidney axis in IgA nephropathy (2016) (100)
Pathophysiology of cyclosporin A nephrotoxicity: experimental and clinical observations. (1992) (94)
Treatment of IgA nephropathy. (2006) (93)
Expression of J chain mRNA in duodenal IgA plasma cells in IgA nephropathy. (1994) (91)
Sequential study of the IgA system in relapsing IgA nephropathy. (1986) (91)
Early measurement of interstitial fibrosis predicts long‐term renal function and graft survival in renal transplantation (1996) (90)
Vascular endothelial growth factor mRNA expression in minimal change, membranous, and diabetic nephropathy demonstrated by non-isotopic in situ hybridisation. (1999) (88)
New insights into the pathogenesis of IgA nephropathy (2003) (85)
Treatment of IgA nephropathy and Henoch–Schönlein nephritis (2013) (82)
Progressive Resistance Exercise Training in CKD: A Feasibility Study. (2015) (81)
Glomerular disease as a cause of isolated microscopic haematuria. (1994) (81)
Global access of patients with kidney disease to health technologies and medications: findings from the Global Kidney Health Atlas project. (2018) (80)
Effective CKD care in European countries: challenges and opportunities for health policy. (2015) (78)
Does nifedipine ameliorate cyclosporin A nephrotoxicity? (1987) (78)
IS CHRONIC RENAL TRANSPLANT REJECTION A NON-IMMUNOLOGICAL PHENOMENON? (1986) (78)
Benefits of regular walking exercise in advanced pre-dialysis chronic kidney disease. (2012) (77)
The prevalence of diagnosed systemic lupus erythematosus in whites and Indian Asian immigrants in Leicester city, UK. (1992) (76)
Immunopathogenesis of IgAN (2007) (76)
Training nephrologists from developing countries: does it have a positive impact? (2012) (75)
Correcting impotence in the male dialysis patient: experience with testosterone replacement and vacuum tumescence therapy. (1998) (72)
High risk acute renal failure. (1986) (72)
Exaggerated systemic antibody response to mucosal Helicobacter pylori infection in IgA nephropathy. (1999) (71)
IgA nephropathy. (2005) (70)
Immune mechanisms in glomerular IgA deposition. (1988) (66)
IgA myeloma presenting as Henoch-Schönlein purpura with nephritis. (2000) (64)
High incidence of minimal change nephrotic syndrome in Asians. (1985) (63)
Chapter 3: UK ESRD Incident Rates in 2008: national and centre-specific analyses (2010) (63)
Erythropoietin and sexual dysfunction. (1997) (62)
Risk HLA-DQA 1 and PLA 2 R 1 Alleles in Idiopathic Membranous Nephropathy (2011) (62)
Distinguishing C1q nephropathy from lupus nephritis. (2004) (60)
Chronic kidney disease: Health burden of kidney disease recognized by UN (2012) (60)
Identification of a novel Fcα receptor expressed by human mesangial cells (2000) (59)
Increased dimeric IgA‐producing B cells in tonsils in IgA nephropathy determined by in situ hybridization for J chain mRNA (1995) (59)
Outcome of acute renal failure following surgical repair of ruptured abdominal aortic aneurysms. (2000) (59)
Deterioration in renal function associated with angiotensin converting enzyme inhibitor therapy is not always reversible (1992) (58)
High incidence of end-stage renal disease in Indo-Asians in the UK. (1995) (57)
Tonsillectomy in a European Cohort of 1,147 Patients with IgA Nephropathy (2015) (57)
Treatment and outcome of adult patients with primary focal segmental glomerulosclerosis in five UK renal units. (2005) (56)
Glomerular IgA deposition in liver disease. (1999) (53)
The pathogenic role of IgA1 O‐linked glycosylation in the pathogenesis of IgA nephropathy (Review Article) (2007) (52)
T-cell homing receptor expression in IgA nephropathy. (2007) (51)
Diabetic renal disease: differences between Asian and white patients. (1986) (51)
Primary IgA nephropathy: new insights into pathogenesis. (2011) (49)
Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update. (2018) (49)
Immune complex formation in IgA nephropathy: a case of the 'right' antibodies in the 'wrong' place at the 'wrong' time? (2009) (49)
Structural features of IgA molecules which contribute to IgA nephropathy. (1999) (48)
A quantitative study comparing adjustment and acceptance of illness in adults on renal replacement therapy. (1999) (47)
B-cell O-galactosyltransferase activity, and expression of O-glycosylation genes in bone marrow in IgA nephropathy. (2008) (46)
Systemic and mucosal IgA responses to systemic antigen challenge in IgA nephropathy. (1993) (46)
Ethical issues in dialysis therapy (2017) (44)
"Saving Young Lives" with acute kidney injury: the challenge of acute dialysis in low-resource settings. (2016) (44)
Long‐ and short‐term outcomes in renal allografts with deceased donors: A large recipient and donor genome‐wide association study (2018) (44)
Primary tuberculosis of the esophagus. (1984) (44)
The role of continuous ambulatory peritoneal dialysis in end-stage renal failure due to multiple myeloma. (1990) (42)
Elevation of IgA in IgA nephropathy is localized in the serum and not saliva and is restricted to the IgA1 subclass. (1993) (41)
Peritoneal Dialysis to Treat Patients with Acute Kidney Injury—The Saving Young Lives Experience in West Africa: Proceedings of the Saving Young Lives Session at the First International Conference of Dialysis in West Africa, Dakar, Senegal, December 2015 (2017) (41)
Modulation of cellular immune function by cyclophosphamide in children with minimal-change nephropathy. (1984) (40)
Effect of recombinant human erythropoietin on erythropoiesis in homozygous sickle-cell anaemia and renal failure. (1992) (39)
IgA nephropathy and Henoch-Schönlein purpura (1999) (39)
Influence of nifedipine on interstitial fibrosis in renal transplant allografts treated with cyclosporin A. (1994) (39)
Ethnicity and renal disease. (2005) (38)
The DQw7 allele at the HLA-DQB locus is associated with susceptibility to IgA nephropathy in Caucasians. (1991) (37)
Global overview of health systems oversight and financing for kidney care. (2018) (37)
β1,4-galactosyltransferase 1 is a novel receptor for IgA in human mesangial cells. (2017) (37)
Increased immunoglobulin A and immunoglobulin A1 cells in bone marrow trephine biopsy specimens in immunoglobulin A nephropathy. (1994) (37)
IgA1 glycosylation and the pathogenesis of IgA nephropathy. (2000) (36)
Patient and Staff Perceptions of Intradialytic Exercise before and after Implementation: A Qualitative Study (2015) (35)
Global Kidney Health Atlas (GKHA): design and methods. (2017) (34)
RCPE UK consensus conference statement: Management of acute kidney injury: the role of fluids, e-alerts and biomarkers. (2013) (32)
The value of urine screening in a young adult population. (2004) (32)
Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial. (2022) (32)
IgA nephropathy--a disorder of IgA production? (1997) (32)
Age-Related Variations in Presentation and Outcome in Wegener's Granulomatosis (1997) (32)
Accelerated Hypertriglyceridemia in Patients on Continuous Ambulatory Peritoneal Dialysis - A Preventable Abnormality (1981) (32)
Chapter 4: UK ESRD Prevalent Rates in 2008: national and centre-specific analyses (2010) (30)
The nucleotide sequence of the IgA1 hinge region in IgA nephropathy. (1998) (30)
Renal and haemodynamic effects of amlodipine and nifedipine in hypertensive renal transplant recipients. (1998) (30)
Acute renal failure associated with haematological malignancies: A review of 10 years experience (1991) (30)
Treatment of ethylene glycol poisoning with peritoneal dialysis. (1982) (30)
Adrenal dysfunction in patients with renal amyloid. (1990) (30)
IgA nephropathy at two score and one. (2010) (30)
Improving global health: measuring the success of capacity building outreach programs: a view from the International Society of Nephrology. (2016) (30)
Parathyroidectomy in chronic renal failure: comparison of three operative strategies. (1996) (29)
Capturing and monitoring global differences in untreated and treated end-stage kidney disease, kidney replacement therapy modality, and outcomes. (2020) (29)
UK Renal Registry 11th Annual Report (December 2008): Chapter 4 ESRD prevalent rates in 2007 in the UK: national and centre-speciﬁc analyses (2009) (29)
The effect of nifedipine on renal function in normotensive cyclosporin-A-treated renal allograft recipients. (1990) (29)
Crossover comparison of intravenous and subcutaneous erythropoietin in haemodialysis patients. (1992) (28)
The pathogenic role of immunoglobulin A polymers in immunoglobulin A nephropathy. (1993) (28)
Peritoneal Dialysis, Acute Kidney Injury, and the Saving Young Lives Program (2014) (28)
Saving Young Lives: provision of acute dialysis in low-resource settings (2015) (28)
The beneficial effects of oral nifedipine on cyclosporin-treated renal transplant recipients — a randomised prospective study (1996) (28)
The Genetics of IgA Nephropathy: An Overview from Western Countries (2015) (26)
Expression of the mucosal γδ T cell receptor V region repertoire in patients with IgA nephropathy (1997) (26)
Renal effects of amlodipine in normotensive renal transplant recipients. (1999) (26)
Early detection of chronic kidney disease (2008) (25)
Rate of decline in renal function in Indo‐Asians and Whites with diabetic nephropathy (1998) (25)
Predicting prognosis in IgA nephropathy. (2001) (25)
Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool. (2020) (25)
Global coverage of health information systems for kidney disease: availability, challenges, and opportunities for development. (2018) (25)
Renal replacement therapy for refugees with end-stage kidney disease: an international survey of the nephrological community. (2016) (24)
Effects of acute and chronic hypohydration on kidney health and function. (2015) (24)
CHAPTER 15 – Introduction to Glomerular Disease: Clinical Presentations (2010) (24)
Time to move forward (2007) (24)
Familial membranous nephropathy. (1984) (24)
Correction of Metabolic Acidosis and the Protein Catabolic Rate in Pd Patients (1994) (23)
Turnover of human tubular cells exposed to proteins in vivo and in vitro. (2001) (23)
IgA nephropathy: progress before and since Berger. (2011) (23)
Kidney care in low- and middle-income countries. (2019) (22)
Disease variations in Asians in Leicester. (1993) (22)
Plasma erythropoietin levels and acquired cystic disease of the kidney in patients receiving regular haemodialysis treatment (1991) (22)
CHAPTER 22 – IgA Nephropathy and Henoch-Schönlein Nephritis (2010) (21)
Chapter 4 ESRD prevalent rates in 2007 in the UK: national and centre-specific analyses (2007) (21)
Classi fi cation of IgA nephropathy 2016 — the role of crescentic lesions : an update from the IgA Nephropathy Classi fi cation Working Group (2017) (21)
INCREASING FREQUENCY OF ADULT IgA NEPHROPATHY IN THE UK? (1987) (21)
Low antibody affinity restricted to the IgA isotype in IgA nephropathy (1994) (20)
The new Oxford Clinico-Pathological Classification of IgA nephropathy. (2010) (20)
Effect of nifedipine on renal haemodynamics in an animal model of cyclosporin A nephrotoxicity. (1990) (19)
Challenges of access to kidney care for children in low-resource settings (2020) (19)
Identification of a novel Fcalpha receptor expressed by human mesangial cells. (2000) (19)
Simultaneous in situ hybridisation of native mRNA and immunoglobulin detection by conventional immunofluorescence in paraffin wax embedded sections. (1992) (19)
Clinical Experience with Icodextrin in Continuous Ambulatory Peritoneal Dialysis Patients (1994) (19)
RED-CELL SURFACE CHARGE IN GLOMERULAR DISEASE (1986) (18)
Recurrent proteinuria in chronic lymphocytic leukemia. (1981) (18)
Gm allotypes in membranous nephropathy. (1983) (18)
A case of microscopic polyarteritis associated with antineutrophil cytoplasmic antibodies. (1987) (18)
Origin and structure of pathogenic IgA in IgA nephropathy. (1997) (18)
IgA nephropathy: "State of the art": a report from the 15th International Symposium on IgA Nephropathy celebrating the 50th anniversary of its first description. (2019) (18)
Calcium channel blockers and cyclosporine metabolism. (1989) (18)
Diabetes and renal failure in Indo-Asians in the UK--a paradigm for the study of disease susceptibility. (1997) (18)
Dietary protein manipulation in experimental nephrotic syndrome. (1988) (18)
New insights into the pathogenesis of IgA nephropathy - Pathogenesis of IgA nephropathy (2003) (18)
Development of a framework for minimum and optimal safety and quality standards for hemodialysis and peritoneal dialysis. (2020) (18)
Lack of awareness of kidney complications despite familiarity with diabetes: a multi-ethnic qualitative study. (2011) (18)
Combined walking exercise and alkali therapy in patients with CKD4–5 regulates intramuscular free amino acid pools and ubiquitin E3 ligase expression (2013) (17)
International IgA nephropathy network clinico-pathological classification of IgA nephropathy. (2007) (17)
Henoch-Schönlein purpura with immunoglobulin A nephropathy and abnormalities of immunoglobulin A in a Wiskott-Aldrich syndrome carrier. (1997) (17)
Ethnicity and Renal Replacement Therapy (2010) (16)
The ISN 0by25 Global Snapshot Study (2016) (16)
An antibody-mediated bullous skin eruption caused by chronic renal allograft rejection. (1982) (16)
Expression of the mucosal gamma delta T cell receptor V region repertoire in patients with IgA nephropathy. (1997) (16)
Renal transplant fibrosis: histomorphometric assessment of early renal transplant biopsies for markers of chronic rejection. (1997) (15)
Prevalence of Hypertension and Diabetes and Coexistence of Chronic Kidney Disease and Cardiovascular Risk in the Population of the Republic of Moldova (2012) (15)
IgA glycosylation in IgA nephropathy. (1998) (15)
Expression of T cell receptor variable region families by bone marrow γδ T cells in patients with IgA nephropathy (2002) (15)
Current Nephrological Practice in the Investigation of Haematuria: Relationship to Incidence of IgA Nephropathy (1989) (15)
Comprar Comprehensive Clinical Nephrology, 4th Edition | Richard J. Johnson | 9780323058766 | Mosby (2010) (15)
Current status of health systems financing and oversight for end-stage kidney disease care: a cross-sectional global survey (2021) (15)
Does increasing haemoglobin concentration and haematocrit have a pressor effect in dialysis patients? (1989) (14)
Recognition and management of community-acquired acute kidney injury in low-resource settings in the ISN 0by25 trial: A multi-country feasibility study (2021) (14)
Executive summary and conclusions from the European Hydration Institute Expert Conference on human hydration, health, and performance. (2015) (14)
UK Renal Registry 11th Annual Report (December 2008): Chapter 3 ESRD incident rates in 2007 in the UK: national and centre-speciﬁc analyses (2009) (14)
The population-level costs of immunosuppression medications for the treatment of glomerulonephritis are increasing over time due to changing patterns of practice (2018) (14)
Improved immediate graft function with nifedipine in cyclosporine-treated renal allograft recipients--a randomized prospective study. (1992) (13)
Asymptomatic microscopical haematuria. (1986) (13)
Nifedipine improves immediate, and 6- and 12-month graft function in cyclosporin A (CyA) treated renal allograft recipients. (1992) (13)
IgA Nephropathy, Antineutrophil Cytoplasmic Antibodies and Crescentic Glomerulonephritis in a Patient with the Hermansky-Pudlak Syndrome (2001) (13)
Listeria Monocytogenes Peritonitis Complicating CAPD (1989) (13)
Autoantibodies in IgA nephropathy. (1995) (12)
Response of circulating immune complexes to food challenge in relapsing IgA nephropathy (1987) (12)
Nephrology in developing countries: the ISN's story (2014) (12)
Microscopic haematuria Role of renal biopsy is undervalued (1994) (12)
A call to action on World Kidney Day, 8 March 2007. (2007) (11)
A comparative study of digoxigenin, 2,4-dinitrophenyl, and alkaline phosphatase as deoxyoligonucleotide labels in non-radioisotopic in situ hybridisation. (1997) (11)
Elective conversion from cyclosporine to azathioprine: long-term follow-up. (1987) (11)
An update on the treatment of IgA nephropathy (2017) (11)
Global capacity for clinical research in nephrology: a survey by the International Society of Nephrology. (2018) (11)
Ethnicity and renal disease: questions and challenges. (2003) (11)
Sezary cell lymphoma following cyclosporin immunosuppression for renal transplantation. (1991) (10)
Gut permeability in IgA nephropathy. (1990) (10)
Response to mucosal antigen challenge in IgA nephropathy. (1995) (9)
Increased IgA and decreased IgG production by Epstein-Barr virus transformed B cells in culture in IgA nephropathy. (1994) (9)
The effect of the thromboxane receptor antagonist GR32191B on cyclosporine-induced nephrotoxicity. (1991) (9)
Complications of using OKT3 for induction of immunosuppression in recipients of kidneys from nonheart beating donors. (1994) (9)
Poorer graft survival in ethnic minorities: results from a multi-centre UK study of kidney transplant outcomes. (2011) (9)
A multi-centre qualitative study exploring the experiences of UK South Asian and White Diabetic Patients referred for renal care (2012) (9)
Targeted therapies: Is there a role for rituximab in nephrotic syndrome? (2014) (8)
Recovery of renal function after delayed revascularisation of acute occlusion of the renal artery (1988) (8)
Isolated microscopic haematuria in the genitourinary clinic: the value of renal biopsy (1997) (8)
The Therapeutic Evaluation of Steroids in IgA Nephropathy Global (TESTING) Study: Trial Design and Baseline Characteristics (2021) (8)
Acute renal failure associated with a labetalol overdose. (1990) (8)
Expression of T cell receptor variable region families by bone marrow gammadelta T cells in patients with IgA nephropathy. (2002) (8)
The third World Kidney Day: looking back and thinking forward. (2008) (8)
Urticaria, arthralgia, and nephropathy without amyloidosis: another variant of the Muckle‐Wells syndrome? (1996) (8)
Abnormal IgD and IgA1 O-glycosylation in hyperimmunoglobulinaemia D and periodic fever syndrome (2009) (8)
The third World Kidney Day: looking back and thinking forward (2008) (7)
Immunosuppression in IgA Nephropathy: Guideline Medicine Versus Personalized Medicine. (2017) (7)
Availability, coverage, and scope of health information systems for kidney care across world countries and regions. (2020) (7)
Raising awareness of chronic kidney disease among South Asians and primary care: the ABLE project. (2008) (7)
The International Society of Nephrology (ISN). Roles & challenges in Africa and other resource-limited communities. (2016) (7)
Impaired IgG response to tetanus toxoid in human membranous nephropathy: association with HLA-DR3. (1986) (7)
Epidemiology, baseline characteristics and risk of progression in the first South-Asian prospective longitudinal observational IgA nephropathy cohort (2020) (7)
Strategies for the management of IgA Nephropathy (1994) (7)
Does Low-Calcium Dialysate Improve the Nutritional Status of Capd Patients? (1993) (6)
The kidney in myeloma (1986) (6)
Glucose polymer for ultrafiltration failure in CAPD (1993) (6)
Predicting the future in immunoglobulin A nephropathy: a new international risk prediction tool. (2020) (6)
Disparities in end-stage kidney disease care for children: a global survey. (2020) (6)
Influence of nifedipine on cyclosporin A nephrotoxicity after unilateral nephrectomy in the spontaneously hypertensive rat. (1991) (6)
Act now against new NHS competition regulations (2013) (6)
Visceral Glomerular Epithelial Cell DNA Synthesis in Experimental and Human Membranous Disease (1998) (6)
Variation in IGHMBP2 is not associated with IgA nephropathy in independent studies of UK Caucasian and Chinese Han patients. (2010) (5)
A spoonful of sugar helps the proteinuria go down? (2007) (5)
Towards defining antigens in human membranous nephropathy. (1992) (5)
Is sialylation of IgA the agent provocateur of IgA nephropathy? (2008) (5)
Protocol and rationale for the first South Asian 5-year prospective longitudinal observational cohort study and biomarker evaluation investigating the clinical course and risk profile of IgA nephropathy: GRACE IgANI cohort (2018) (5)
Steroid-resistant nephrotic syndrome with mutations in NPHS2 (podocin): report from a three-generation family (2014) (5)
Treating IgA Nephropathy – Who, When and How? (2003) (5)
Recurrent acute renal failure with interstitial nephritis due to D-penicillamine. (1987) (5)
Predictors of renal function in diabetic and non-diabetic renal disease. (1983) (4)
In vitro immunoglobulin isotype suppression in immunoglobulin A nephropathy. (1994) (4)
Evidence-based classification of glomerular pathology. (2014) (4)
Renal failure due to cholesterol embolisation (1995) (4)
Renal transplantation: nifedipine for the nonstarters? A prospective randomised study. (1993) (4)
Is Serum Creatinine a Reliable Index of Impaired Renal Function in Cyclosporin (CYA) Treated Renal Allograft Recipients (1989) (4)
CHAPTER 16 – Introduction to Glomerular Disease: Histologic Classification and Pathogenesis (2010) (4)
Nutritional Status of Hemodialysis Patients Receiving Recombinant Human Erythropoietin Therapy (1991) (4)
Phosphoinositide hydrolysis is not enhanced by ciclosporin. (1991) (4)
The Effect of Correction of Acidosis on Protein Catabolic Rate (Pcr) in Peritoneal Dialysis (Pd) Patients (1993) (4)
Diabetic kidney disease: act now or pay later Robert C Atkins and Paul Z Zimmet, for the 2010 International Society of Nephrology and International Federation of Kidney Foundations World Kidney Day Steering Committee* and the International Diabetes Federation (2010) (3)
Immunoglobulin A nephropathy and Henoch–Schönlein purpura (2010) (3)
The beneficial effects of oral nifedipine on cyclosporin‐treated renal transplant recipients — a randomised prospective study (1996) (3)
Adverse effects of OKT3 therapy: increased risk with impaired renal function. (1994) (3)
Immunoglobulin A nephropathy: fish oils and beyond. (1996) (3)
Variation in IGHMBP2 is not associated with IgA nephropathy in independent studies of UK Caucasian and Chinese Han patients (vol 25, pg 1547, 2010) (2010) (3)
Deficiency of IgG subclass antibody response to tetanus toxoid associated with high serum IgA levels in IgA nephropathy. (1993) (3)
Is progression of IgA nephropathy conditioned by genes regulating atherosclerotic damage? (2009) (3)
Chapter 27 – The Molecular Basis of IgA Nephropathy (2008) (3)
The third World Kidney Day: Looking back and thinking forward. (2008) (3)
The International Society of Nephrology (ISN) and the American Nephrologists of Indian Origin (ANIO) Online Clinical Nephropathology Certificate (CNC) program. (2016) (3)
Is Indian origin a risk factor in cadaveric renal transplantation? (1992) (3)
Genome-Wide Analysis Identifies Strong Association Between HLA and IgA Nephropathy (2010) (2)
The third World Kidney Day: looking back and thinking forward. (2008) (2)
IgA nephropathy: introduction. (2008) (2)
TO013PROTEINURIA REDUCTION IN IGA NEPHROPATHY BY NEFECON, A TARGETED‑RELEASE FORMULATION OF BUDESONIDE - RESULTS FROM THE NEFIGAN TRIAL (2017) (2)
Mutant mice provide new insight into the role of (mis-)glycation in IgA nephropathy and other glomerular diseases. (2007) (2)
A unique role in global nephrology: The International Society of Nephrology, 2011–2020 (2020) (2)
Abnormalities of IgA1 production in IgA nephropathy (2002) (2)
ObituaryJean Berger (1930–2011) (2011) (2)
Immunosuppression for recipients of kidneys from non-heart-beating donors: comparison of triple therapy and OKT3 regimens. (1996) (2)
The impact of the OFAC regulations on the work of ISN. (2006) (2)
The International Society of Nephrology: what does "philanthropic" mean for members? (2009) (2)
Treatment of severe refractory atopic dermatitis with cyclosporin (1991) (2)
Clinical nephrology - IgA nephropathy, lupus nephritis, vasculitis (2013) (2)
Treatment of steroid resistant rejection following renal transplantation: benefits and risks of OKT3 therapy. (1996) (2)
Contents Vol. 59, 1999 (1999) (2)
Lesson of the Week: Value of opinion by oral physician in diagnosing Wegener's granulomatosis (1994) (2)
Three-Year Clinical Outcomes of the First South Asian Prospective Longitudinal Observational IgA Nephropathy Cohort (2021) (2)
In memoriam: Oliver M. Wrong. (2012) (2)
Locally Prepared Solutions for Treating AKI in Low-Resource Environments (2018) (2)
The Third World Kidney Day: looking back and thinking forward. (2008) (2)
Focal segmental glomerulosclerosis: challenges in definitions, pathogenesis and management (2017) (2)
CAPD: Successful Use in the Treatment of Nephrology Ascites (1989) (2)
Should Immunosuppressive Therapy Be Used in Slowly Progressive IgA Nephropathy? (2016) (2)
Corrections to “A comparison of the results of renal transplantation from non-heat-beating, conventional cadaveric, and living donors. Kidney Int 58:2585–2591, 2000” (2001) (1)
The Effect of Nifedipine (NIF) on [3H]-Cyclosporin a (CYA) Uptake Into Human Proximal Tubular Cells (PTC) (1990) (1)
The Third World Kidney Day: looking back and thinking forward (2008) (1)
Appendix G: Coding: Ethnicity, EDTA Primary Renal Diagnoses, EDTA Causes of Death and Treatment Timeline Modality Codes (2010) (1)
Appendix E: Additional Data Tables for 2008 new and existing patients (2010) (1)
Immunoglobulin A nephropathy and IgA vasculitis (HSP) (2020) (1)
The ISN's Fellowship Program: investing in the global future of nephrology (2006) (1)
The Changing Face of End Stage Renal Disease in a UK Renal Unit (1989) (1)
Other Non-Immunomodulatory Agents (2009) (1)
Thin membrane nephropathy (2010) (1)
Response to ‘Nomenclature of the Oxford classification of IgA nephropathy: do we need to be careful?’ (2010) (1)
A call to action on World Kidney Day, 8 March 2007 (Editorial) (2007) (1)
T Lymphocyte Subpopulations and Lymphocyte Function in Minimal Change Nephropathy (MCN) during Long Term Remission (1983) (1)
Kidney Disease in Ethnic Minority Populations of the United Kingdom (2005) (1)
Appendix I: Laboratory Conversion Factors (2010) (1)
The impact of national chronic kidney disease management guidelines in the United Kingdom on referral patterns for South Asian and european patients with type 2 diabetes mellitus (2013) (1)
A Nephrologist on Sabbatical Leave in the USA (1994) (1)
20 – Immunoglobulin A Nephropathy and Related Disorders (2014) (1)
Culyer, research governance, and all that (2002) (1)
Nifedipine improves immediate, and 6‐ and 12‐month graft function in cyclosporin A (CyA) treated renal allograft recipients (1992) (1)
The third World Kidney Day: Looking back and thinking forward (Editorial) (2008) (1)
Pathogenesis of IgA nephropathy. (1999) (1)
Appendix D: Methodology used for Analyses of PCT/ Local Authority Incidence and Prevalence Rates and of Standardised Ratios (2010) (1)
IgA Nephropathy: Evidence of Abnormal Mucosal Immunity (1994) (1)
The nephritogenic immune response. (1994) (1)
Progressive resistance exercise training in Chronic Kidney Disease : A 2 feasibility study (2015) (1)
The Effect of Cyclosporin a (CYA) on Phosphoinositide (PI) Hydrolysis in Rat Aorta and Resistance Arterioles (1989) (1)
CAPD: successful use in the treatment of nephrogenic ascites. (1989) (1)
ERA-EDTA Immunonephrology working group. (2010) (1)
MAJOR ELEMENTS IN THE PATHOGENESIS OF IgA NEPHROPATHY (1)
STOPping peanut allergy: the saga of food oral immunotherapy (2014) (1)
Glomerulonephritis from a chronically infected implanted device (2015) (1)
Identification of β 1 , 4-galactosyltransferase 1 as a novel receptor for IgA in human mesangial cells (2018) (0)
Progression & risk factors CKD 1-5 (2) (2011) (0)
World Kidney Forum IgA Nephropathy: Progress Before and Since Berger (2011) (0)
Effect Of Acute And Regular Exercise On CD4+ Lymphocyte Activation In Chronic Kidney Disease Patients: 1694 (2009) (0)
Does Increasing Haemoglobin (Hb) or Haematocrit (Hct) Have a Pressor Effect in Dialysis Patients (1989) (0)
UK Renal Registry 11th Annual Report (December 2008): Appendix D Methodology used for analyses of PCT incidence and prevalence rates and of standardised ratios (2009) (0)
Novel territory for neutrophils in the pathogenesis of ANCA-associated vasculitides ∗ (2009) (0)
Patient and staff perceptions of intradialytic exercise before and after implementation (2015) (0)
WORLD KIDNEY DAY 2008 A MESSAGE TO THE KIDNEY COMMUNITY OF IRAN (LETTER TOEDITOR) (2008) (0)
Identification of J-Chain mRNA in Duodenal Lamina Propria in IGA Nephropathy (IgAN) (1991) (0)
Malnutrition & inflammation in CKD 1-5 (2011) (0)
Long-and short-term outcomes in renal allografts with deceased donors : A (2018) (0)
UK Renal Registry 11th Annual Report (December 2008): Appendix E Additional data tables for 2007 new and existing patients (2009) (0)
6. IgA nephropathy and Henoch-Schonlein purpura (1999) (0)
Lab methods, progression & risk factors for CKD - 1 (2009) (0)
Contents Vol. 111, Suppl 1, 2009 (2009) (0)
The Third World Kidney Day: looking back and thinking forward. (2008) (0)
Nifedipine does not inhibit ciclosporin A uptake into human cultured proximal tubular cells. (1991) (0)
Epidemiology and CKD - 1 (2009) (0)
Textbook of Nephro-Endocrinology (2009) (0)
UK Renal Registry 11th Annual Report (December 2008): Appendix J Abbreviations used for the renal centre names in the figures and data tables (2009) (0)
In memoriam: Donal O'Donoghue, 1956-2021. (2021) (0)
UK Renal Registry 11th Annual Report (December 2008): Appendix F UK Renal Registry dataset speciﬁcation (2009) (0)
SP104IS THERE LONG-TERM VALUE OF PATHOLOGY SCORING IN IGA NEPHROPATHY? A VALIGA UPDATE (2017) (0)
Does the Rate of Progression of Diabetic Nephropathy Differ between Two Ethnic Groups - Whites and Indo-Asians (1997) (0)
Lab methods, progression & risk factors for CKD - 2 (2009) (0)
On behalf of the Working Group of the International IgA Nephropathy Network & Renal Pathology Society (2010) (0)
Identification of a Novel Foa Receptor Expressed by Human Mesangial Cells (1998) (0)
UK Renal Registry 11th Annual Report (December 2008): Appendix A The UK Renal Registry statement of purpose (2009) (0)
UK Renal Registry 11th Annual Report (December 2008): Appendix B Deﬁnitions and analysis criteria (2009) (0)
UK Renal Registry 11th Annual Report (December 2008): Appendix G Coding: Ethnicity; EDTA primary renal diagnoses and EDTA causes of death (2009) (0)
MO040 RISK FACTORS FOR PROGRESSION IN CHILDREN WITH IgA NEPHROPATHY: DATA FROM A EUROPEAN COHORT (2013) (0)
Contents Vol. 115, Suppl 1, 2010 (2010) (0)
Transplantation Renal and haemodynamic e V ects of amlodipine and nifedipine in hypertensive renal transplant recipients (1998) (0)
Impaired renal function in a rural Ugandan population cohort (cid:446)version (cid:697)(cid:402) referees(cid:403) (cid:696) approved with reservations(cid:401) (cid:696) not approved(cid:447) (2019) (0)
Landmark Papers in Nephrology (2013) (0)
Evaluation and management of IgA nephropathy (2012) (0)
Cardiac dysfunction in chronic uraemia (1992) (0)
Appendix H: Acronyms and Abbreviations used in the Report (2010) (0)
DISEASE OF THE MONTH IgA Nephropathy : Recent Developments (2000) (0)
The third World Kidney Day: looking back and thinking forward. (2008) (0)
Simultaneous insituhybridisation ofnative mRNA andimmunoglobulin detection by conventional immunofluorescence (1992) (0)
The third World Kidney Day: looking back and thinking forward (2008) (0)
SAT-377 BIOMARKER EVALUATION OF THE FIRST SOUTH ASIAN PROSPECTIVE LONGITUDINAL COHORT INVESTIGATING THE CLINICAL COURSE AND RISK PROFILE OF IGA NEPHROPATHY: GRACE IGANI COHORT (2020) (0)
Diabetes, Cyclosporin Nephrotoxicity, and Serum Creatinine Concentration (1991) (0)
David N.S. Kerr (1927-2014) (2014) (0)
COMPARINE ADJUSTMENT AND ADULTS ON RENAL REPLACEMENT THERAPY (1999) (0)
Abnormalities of IgA1 production in IgA nephropathy (2002) (0)
Haiti and elsewhere: global disaster nephrology (2010) (0)
Appendix F: UK Renal Registry Dataset Specification (2010) (0)
Chapter 16 – IgA Nephropathy and Henoch-Schönlein Purpura (2008) (0)
A call to action on world kidney day, march 8, 2007. Commentary (2007) (0)
Amyloid tumour in association with ovarian fibroma (1991) (0)
UK Renal Registry 11th Annual Report (December 2008): Appendix I Laboratory conversion factors (2009) (0)
Acute renal failure associated withalabetalol overdose (1990) (0)
ISN moments—238 young Chinese nephrologists supported to learn from the World Congress of Nephrology 2013 (2014) (0)
Treatments Options for IgA Nephropathy (2005) (0)
Epidemiology and CKD - 3 (2009) (0)
Erratum: Variation in IGHMBP2 is not associated with IgA nephropathy inindependent studies of UK Caucasian and Chinese Han patients (Nephrology Dialysis Transplantation (2010): doi: 10.1093/ndt/gfp661) (2010) (0)
Paediatric nephrology - A (2013) (0)
The Effect of an Oral Protein Load on Renal Haemodynamics in Cyclosporin and Azathioprine Renal Allograft Recipients (1989) (0)
Antony John Wing (2012) (0)
Dietary Protein Manipulation in Experimental Nephrotic Syndrome (NS) (1987) (0)
Nephrology around the World: Opportunities for Progress (2013) (0)
UK Renal Registry 11th Annual Report (December 2008): Appendix H Acronyms and abbreviations used in the Report (2009) (0)
Japan: crisis and recovery. (2011) (0)
Steroids and immunoglobulin A nephritis. Authors' reply (2006) (0)
Who should be an author (1984) (0)
UK Renal Registry 11th Annual Report (December 2008): Appendix C Renal services described for non-physicians (2009) (0)
Self-assessment questions: Evaluation and management of IgA nephropathy (2012) (0)
Management of immunosuppression in renal transplant patients with septicaemia. (1992) (0)
Appendix J: Renal Centre Names and Abbreviations used in the Figures and Data Tables (2010) (0)
Disease of the Month IgA Nephropathy (2005) (0)
Age, CKD and other kidney messages (2014) (0)
Appendix A: The UK Renal Registry Statement of Purpose (2010) (0)
Subject Index, Vol. 59, 1991 (1991) (0)
The Third World Kidney Day: Looking Back and Thinking Forward (2007) (0)
Response to ‘Steroids and IgA nephritis’ (2006) (0)
A physician with endocarditis (1995) (0)
Combined walking exercise and alkali therapy in patients with CKD4–5 regulates intramuscular free amino acid pools and ubiquitin E3 ligase expression (2013) (0)
Clinical Nephrology: primary and secondary glomerulonephritis (2011) (0)
Poster Presentations (2013) (0)
Recovery ofrenal function after delayed revascularisatio n of acuteocclusion oftherenal artery (1988) (0)
POS-103 Serum and Glomerular Complement Components as Biomarkers in the First South-Asian Prospective Longitudinal Observational IgA Nephropathy cohort (GRACE-IgANI) (2022) (0)
National health policies and strategies for addressing chronic kidney disease: Data from the International Society of Nephrology Global Kidney Health Atlas (2023) (0)
IgA Nephropathy in Adults and Children (2009) (0)
Diabetes and renal disease (2013) (0)
World Kidney Day 2011: protect your kidneys, save your heart. (2011) (0)
Speaker Abstracts: Tuesday, 6 February 2007 (2007) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Johan Feehally?

Johan Feehally is affiliated with the following schools:

University of Leicester